0001093557-20-000109.txt : 20200325 0001093557-20-000109.hdr.sgml : 20200325 20200325181053 ACCESSION NUMBER: 0001093557-20-000109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200313 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOUBLEDAY RICHARD CENTRAL INDEX KEY: 0001466545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 20743437 MAIL ADDRESS: STREET 1: C/O DEXCOM, INC. STREET 2: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-03-13 0 0001093557 DEXCOM INC DXCM 0001466545 DOUBLEDAY RICHARD 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP Chief Commercial Officer Common Stock 2020-03-13 4 G 0 523 0.0 D 51482 D Common Stock 2020-03-23 4 S 0 231 207.7086 D 10483 I by Trust Common Stock 2020-03-23 4 S 0 1300 209.55 D 9183 I by Trust The transaction represents a gift by the Reporting Person of 523 shares to a charitable donor advised fund. Included in this number are 35,492 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 10,910 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021. On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $207.28 to $208.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. By: Jereme Sylvain For: Richard B Doubleday 2020-03-25